Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil
- 18 April 2008
- journal article
- pharmacogenetics
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 64 (7) , 673-681
Abstract
To determine the frequency of N-acetyltransferase 2 (NAT2) polymorphisms, the NAT2 acetylation profile and its relation to the incidence of gastrointestinal adverse drug reactions (ADRs), anti-tuberculosis (TB) drug-induced hepatotoxicity, and the clinical risk factors for hepatotoxicity in a population from Brazil.Keywords
This publication has 33 references indexed in Scilit:
- Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosisTuberculosis, 2007
- Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of BrazilMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and ParaguayMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2007
- II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004Jornal Brasileiro de Pneumologia, 2004
- Pharmacoeconomics of adverse drug reactionsFundamental & Clinical Pharmacology, 2004
- Polymorphism of the N -acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitisHepatology, 2002
- Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.Thorax, 1996
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990
- Hepatic toxicity in south indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamideTubercle, 1986
- Clinical Pharmacokinetics of IsoniazidClinical Pharmacokinetics, 1979